Home 
Blogs Chief Editor Rob Wright Rob Wright
Blogs Chief Editor Rob Wright Rob Wright
Editorial Board Blogs
-
Commercialization, Collaboration Mark Day Two at BIO’s World Congress
Commercialization, Collaboration Mark Day Two at BIO’s World Congress
Several companies made announcements yesterday during BIO’s 10th Annual World Congress on Industrial Biotech showcasing industry collaboration and commercial production. During a morning breakout session, Direct Conversion of Methane to Higher Value Products Using Biological Systems, Josh Silverman of Calysta[…]
Source: BIOtechNow
-
Drawing: A Life Lesson
Drawing: A Life Lesson
By John Baldoni, Chair, Leadership Development, N2growth
“John, do you understand what’s going on in this class?”
My college art instructor asked me that question nearly 40 years ago and I remember his words as if they were said yesterday. I[…]
Source: N2Growth Blog
-
Building a Supply Chain to Go From Seed to Sky
Building a Supply Chain to Go From Seed to Sky
Several workshops took place at BIO’s World Congress today including Building the Aviation Biofuels Supply Chain Network. The workshops are designed for specific and focused discussions on business or technical information and this one looked at Agrisoma as a case[…]
Source: BIOtechNow
-
5 Transitions Great Leaders Make That Average Leaders Don’t
5 Transitions Great Leaders Make That Average Leaders Don’t
By Mike Myatt, Chief Executive Officer, N2growth
The secret to leadership is there aren’t any real secrets. The best leaders have simply gone to school on improving their tradecraft. While the capabilities possessed by the best leaders might seem otherworldly to many,[…]
Source: N2Growth Blog
-
BCG Weighs In On First-In-Class Vs. Best-In-Class Drugs — How Valuable Is Their Advice?
BCG Weighs In On First-In-Class Vs. Best-In-Class Drugs — How Valuable Is Their Advice?
The hardest decisions facing a head of a pharmaceutical R&D organization involve determining which great ideas to fund. One might think this is a simple process, that any idea which can lead to a new drug to treat cancer, Alzheimer’s[…]
Source: Drug Truths
-
NEJM Sheds Light On Payments To Doctors
NEJM Sheds Light On Payments To Doctors
It should come as no surprise that pharmaceutical companies pay doctors for a variety of reasons such as research, lecturing, and teaching. Such payments are justified as these physicians tend to be in demand as experts and their expertise is[…]
Source: Drug Truths
-
Careering around in Cheltenham!
Careering around in Cheltenham!
Careering around in Cheltenham! By Katrina Brockbank Last month I attended the Cheltenham Festivals “Careering Around” careers fair. Run by STEMNET (Science, Technology, Engineering and Mathematics network) the careers fair aimed to introduce young people to the professional opportunities that[…]
Source: Freeman Technology - Free Flow
-
The missing link?
The missing link?
The missing link? By Tim Freeman I recently attended the Arden House Conference (48th AAPS Annual Arden House Conference) which this year was focusing on advances in pharmaceutical material characterisation and their importance in the effective application of QbD. There[…]
Source: Freeman Technology - Free Flow
By A Web Design
